These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease. Geerts H IDrugs; 2007 Feb; 10(2):121-33. PubMed ID: 17285465 [TBL] [Abstract][Full Text] [Related]
4. Peru-1 5 (AVANT). Jones T Curr Opin Investig Drugs; 2004 Aug; 5(8):887-91. PubMed ID: 15600246 [TBL] [Abstract][Full Text] [Related]
5. Taranabant, a novel cannabinoid type 1 receptor inverse agonist. Fremming BA; Boyd ST Curr Opin Investig Drugs; 2008 Oct; 9(10):1116-29. PubMed ID: 18821475 [TBL] [Abstract][Full Text] [Related]
6. SNS-595, a naphthyridine cell cycle inhibitor and stimulator of apoptosis for the treatment of cancers. Mills DA; Fekrazad HM; Verschraegen CF Curr Opin Investig Drugs; 2008 Jun; 9(6):647-57. PubMed ID: 18516764 [TBL] [Abstract][Full Text] [Related]
7. Iclaprim, a diaminopyrimidine dihydrofolate reductase inhibitor for the potential treatment of antibiotic-resistant staphylococcal infections. Peppard WJ; Schuenke CD Curr Opin Investig Drugs; 2008 Feb; 9(2):210-25. PubMed ID: 18246524 [TBL] [Abstract][Full Text] [Related]
8. AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancer. Tamm I Curr Opin Investig Drugs; 2008 Jun; 9(6):638-46. PubMed ID: 18516763 [TBL] [Abstract][Full Text] [Related]
9. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection. Fletcher PS; Shattock RJ Curr Opin Investig Drugs; 2008 Feb; 9(2):189-200. PubMed ID: 18246522 [TBL] [Abstract][Full Text] [Related]
10. Alferminogene tadenovec, an angiogenic FGF4 gene therapy for coronary artery disease. Flynn A; O'Brien T IDrugs; 2008 Apr; 11(4):283-93. PubMed ID: 18379964 [TBL] [Abstract][Full Text] [Related]
17. Hemospan: a hemoglobin-based oxygen carrier for potential use as a blood substitute and for the potential treatment of critical limb ischemia. Smani Y Curr Opin Investig Drugs; 2008 Sep; 9(9):1009-19. PubMed ID: 18729008 [TBL] [Abstract][Full Text] [Related]
18. Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia. Longhurst H Curr Opin Investig Drugs; 2008 Mar; 9(3):310-23. PubMed ID: 18311668 [TBL] [Abstract][Full Text] [Related]
19. Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection. Parish D; Scheinfeld N Curr Opin Investig Drugs; 2008 Feb; 9(2):201-9. PubMed ID: 18246523 [TBL] [Abstract][Full Text] [Related]
20. Axitinib, a novel anti-angiogenic drug with promising activity in various solid tumors. Choueiri TK Curr Opin Investig Drugs; 2008 Jun; 9(6):658-71. PubMed ID: 18516765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]